展望"十五五"开局之年，大同区将继续坚持创新驱动发展战略，持续优化市场化、法治化、国际化营商 环境，深化对专精特新企业的培育与支持，推动传统产业转型升级与新兴产业培育壮大协同并进，奋力 谱写工业经济高质量发展新篇章，为区域经济社会发展作出更大贡献。 在农业生物技术领域，大同区同样涌现出一批创新型"专精特新"企业，大东农生物科技便是其中的典型 代表。企业凭借在农业生物技术领域的持续深耕与创新突破，自主研发的新型产品有效助力绿色农业发 展与养殖业降本增效，先后斩获多项行业奖项与国家专利，彰显了卓越的科技创新能力，成为大同区工 业经济"补短板、锻长板"的中坚力量。 高新技术企业的快速成长，离不开优质营商环境的硬支撑。大同区深入实施"企业包联+问题闭环"服务 机制，针对企业在用地、融资及市场开拓等方面的实际需求，指派专人提供"一对一"精准对接与全程指 导。同时，全力为企业发展开辟"绿色通道"，简化审批流程、提供并联审批，大幅压缩项目落地与投产 周期，全力助推企业快速发展。 目前，数字化智能车间已全面投入运营，深度融合物联网、大数据等先进技术，通过数字化手段将严格 的食品安全标准内嵌于生产全流程，推动品质管控模式从"经 ...

天眼查App显示，近日，河北省永利恒昌农业生物科技有限责任公司成立，法定代表人为黄永利，注册 资本1000万人民币，经营范围为一般项目：农林废物资源化无害化利用技术研发;新型有机活性材料销 售;农业科学研究和试验发展;生物有机肥料研发;农林牧渔业废弃物综合利用;农业生产托管服务;畜禽粪 污处理利用;肥料销售;水果种植;谷物种植;棉花种植;豆类种植;薯类种植;花卉种植;蔬菜种植;谷物销售;豆 及薯类销售;农产品的生产、销售、加工、运输、贮藏及其他相关服务;农副产品销售;污水处理及其再生 利用;水环境污染防治服务;水污染治理;资源再生利用技术研发;土壤污染治理与修复服务（除依法须经 批准的项目外，凭营业执照依法自主开展经营活动）许可项目：肥料生产;活禽销售;饲料生产;动物无害 化处理;牲畜屠宰;家禽屠宰;生猪屠宰（依法须经批准的项目，经相关部门批准后方可开展经营活动，具 体经营项目以批准文件或许可证件为准）。 ...

Financial Data and Key Metrics Changes - As of September 30, 2025, the company's cash and cash equivalents were $23.9 million, sufficient to fund planned operating expenses into early Q2 2026 [20] - Revenue for Q3 2025 was $615,000, a decrease from $1.7 million in the same period last year, reflecting the timing of partner-funded program activities [20] - Research and development expenses decreased to $10.8 million from $13 million year-over-year, primarily due to cost-reduction initiatives [21] - Selling, general, and administrative expenses were reduced to $5.2 million from $7.7 million in the previous year [21] - The net loss for Q3 2025 was $24.3 million, significantly improved from a loss of $201.5 million in the year-ago period, which included a $181.4 million non-cash goodwill impairment charge [22][23] Business Line Data and Key Metrics Changes - The company signed seven RISE customer agreements in the U.S. and Latin America, representing approximately 5-7 million addressable acres for herbicide-tolerant traits HT1 and HT3, with potential annual royalties exceeding $200 million [6][7] - The RISE traits are on track for initial commercial launch in Latin America in 2027, followed by the U.S. in 2028 and Asia around 2030 [8][11] - The biofragrance program achieved critical milestones with successful pre-commercial pilot runs, positioning the company to receive initial payments in Q4 2025 [12] Market Data and Key Metrics Changes - The company is expanding its customer base in Latin America and is positioning for entry into the Asian markets, particularly India, which has approximately 120 million acres under rice cultivation [10][35] - The regulatory environment is improving, with positive determinations in Ecuador and ongoing approvals across North and South America, as well as progress in India and parts of Asia [14] Company Strategy and Development Direction - The company is focused on commercialization and production activities, particularly in weed management traits and biofragrance business, to capture near-term revenue opportunities [4][5] - The streamlined strategic focus has led to significant commercialization momentum, validating the decision to prioritize high-value opportunities [4][5] - The company aims to reduce annual net cash usage to approximately $30 million by 2026 through disciplined capital allocation and operational efficiencies [15][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the gene-editing revolution in agriculture, emphasizing the company's readiness to capitalize on commercialization opportunities [24][25] - The regulatory environment is seen as a catalyst for growth, with expectations for the EU regulatory process to finalize by year-end 2025 [31][33] - The company anticipates initial revenues from biofragrance products in 2026, with a long-term revenue potential in the $20 million-$40 million range [47] Other Important Information - The company has strengthened its board with new appointments to support commercialization efforts [5][6] - The standardized rapid trait development system (RTDS) is recognized as a breakthrough in agricultural innovation, enhancing the company's ability to deliver edited germplasm to customers [11][17] Q&A Session Summary Question: Potential for R&D sharing or bespoke R&D projects in 2026 - Management indicated significant opportunities for expanding R&D collaborations in 2026, driven by regulatory tailwinds and inbound interest for partnerships beyond current focuses [27][28] Question: Timeline for EU regulations finalization - Management believes the final text for EU regulations will be completed by year-end 2025, marking a significant moment for the industry [31][33] Question: Total addressable market for rice in key regions - The company estimates a total addressable market of over 120 million acres in India and 5-7 million acres in Latin America and the U.S. [35][39] Question: Differences between HT traits and pod shatter reduction - Management explained that herbicide-tolerant traits are essential for weed management and have a well-understood business model, making them easier to integrate into breeding programs compared to pod shatter reduction traits [40][41] Question: Revenue expectations for biofragrance products in 2026 - Initial revenues from biofragrance products are expected to be in the single-digit millions, with potential to ramp up significantly in subsequent years [47][55] Question: Update on automation and improvements in the real-time delivery system - Management highlighted improvements in editing frequency and regeneration efficiency, with ongoing automation efforts to enhance operational efficiency [63][64]

Core Insights - A new company, Lincang Dacheng Agricultural Biotechnology Co., Ltd., has been established with a registered capital of 100,000 RMB [1] Company Overview - The legal representative of the company is Ye Er [1] - The company operates in various sectors including new material technology promotion, daily chemical product sales, and information technology consulting [1] - The company is involved in the wholesale and retail of fresh fruits and vegetables, as well as the initial processing and sales of edible agricultural products [1] - The company is permitted to produce feed additives, food additives, and engage in food production and feed production, subject to relevant approvals [1]

Core Insights - The research team, including Shandong University of Technology and several international institutions, developed the PlantLncBoost model to address the challenges of identifying plant lncRNA [1][3][24] - The model achieved an average prediction accuracy of 91.7% across 12 different plant datasets, outperforming existing tools by 18.2% [3][17] - The study highlights the importance of lncRNA in plant growth, development, and environmental adaptation, emphasizing its role in regulating flowering time and responding to climate change [1][2] Model Development - The PlantLncBoost model incorporates 219 novel sequence descriptors based on mathematical theories such as Fourier transform and Shannon entropy [3][6] - The model was trained using a dataset of 24,152 lncRNA sequences from nine angiosperm species, ensuring high reliability through strict quality control [4][7] - Feature selection involved recursive feature elimination (RFE) to identify three core parameters with cross-species discrimination capability [3][11] Performance Evaluation - The model was validated using two key test sets: a comprehensive test set covering 20 diverse plant species and a high-confidence experimental validation set [5][19] - PlantLncBoost demonstrated superior performance with sensitivity at 98.42%, specificity at 94.93%, and accuracy at 96.63%, significantly surpassing other mainstream models [22][21] - The model's ROC curve achieved an AUC of 98.35%, indicating its effectiveness in prediction [19][22] Feature Engineering - A total of 1,662 features were extracted, including traditional sequence-based metrics and innovative mathematical features, enhancing the model's ability to identify lncRNA [6][15] - The model's performance peaked with a lightweight feature set, confirming the effectiveness of using a minimal number of key features [13][15] Collaborative Efforts - The research reflects a growing trend of collaboration between academic institutions and enterprises in advancing plant lncRNA research and applications [24][26] - Innovations in lncRNA research are expected to contribute to sustainable agricultural practices and ecological balance [26][27]

Core Viewpoint - Chengdu Wenjiang National Agricultural Science and Technology Park is actively seeking investment partners through the release of a 2025 investment opportunity list, aiming to enhance its agricultural technology and innovation ecosystem [1][3]. Group 1: Investment Opportunities - The investment opportunity list includes 8 plots of state-owned construction land, 14 plots of collective construction land, 8 research and commercial carriers, and 7 project cooperation resources [3]. - Notable state-owned commercial land includes 36 and 32 acres located in the knowledge economy circle near Sichuan Agricultural University and other agricultural research institutions, positioning it as a core development area for modern urban agriculture [3]. Group 2: Project Collaboration - The Chengdu Wenjiang Modern Urban Agriculture Industrial Park project covers approximately 411.53 acres and includes various functional areas for agricultural production and innovation, aiming to establish a new landmark in modern urban agriculture [4]. - The park is open to collaboration with state-owned enterprises like Longke Group for joint development and operational management, enhancing its competitive edge and regional influence [4]. Group 3: Investor Engagement - The release of the opportunity list has attracted significant interest from investors, with many expressing a desire to strengthen cooperation and explore investment opportunities [4]. - The park's management emphasizes a favorable business environment characterized by supportive policies and dedicated services to facilitate investment and development [4].